INFUSION OF VINCRISTINE AND DOXORUBICIN WITH ORAL DEXAMETHASONE AS FIRST-LINE THERAPY FOR MULTIPLE MYELOMA-Reference-Cited by-同舟云学术

INFUSION OF VINCRISTINE AND DOXORUBICIN WITH ORAL DEXAMETHASONE AS FIRST-LINE THERAPY FOR MULTIPLE MYELOMA

Published:1989-10 Issue:8668 Volume:334 Page:882-885
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Samson Diana,Newland Adrian,Kearney Joseph,Joyner Miles,Mitchell Terry,Barrett A.John,Gaminara Elizabeth,Van De Pette John,McCarthy Donald,Aston Lyn,Hamon Mike,Evans Maggie

Publisher

Elsevier BV

Subject

General Medicine

Reference11 articles.

1. Chemotherapy of previously untreated myeloma patients: an analysis of recent treatment results;Sporn;Semin Oncol,1980

2. A randomised trial of maintenance versus no maintenance melphalan and prednisone in responding myeloma patients;Belch;Br J Cancer,1988

3. Alternating combination chemotherapy and levamisole improves survival in multiple myeloma. A SWOG study;Salmon;J Clin Oncol,1983

4. Results of the MRC myelomatosis trials for patients entered since 1980;MacLennan;Haematol Oncol,1988

5. High-dose intravenous melphalan for plasma-cell leukaemia and myeloma;McElwain;Lancet,1983

Cited by 129 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase I study of the anti-FcRH5 antibody-drug conjugate DFRF4539A in relapsed or refractory multiple myeloma;Blood Cancer Journal;2019-02

2. A phase I, open-label, dose-escalation study of amrubicin in combination with lenalidomide and weekly dexamethasone in previously treated adults with relapsed or refractory multiple myeloma;International Journal of Hematology;2018-05-25

3. Improved survival in multiple myeloma, with a diminishing racial gap and a widening socioeconomic status gap over three decades;Leukemia & Lymphoma;2017-06-09

4. Appendix: Suggested Reading;Dentist's Guide to Medical Conditions, Medications, and Complications;2017-06-02

5. The Choice of Multiple Myeloma Induction Therapy Affects the Frequency and Severity of Oral Mucositis After Melphalan-Based Autologous Stem Cell Transplantation;Clinical Lymphoma Myeloma and Leukemia;2014-08